Lushbaugh W B, Kairalla A B, Hofbauer A F, Arnaud P, Cantey J R, Pittman F E
Am J Trop Med Hyg. 1981 May;30(3):575-85. doi: 10.4269/ajtmh.1981.30.575.
We previously reported partial purification of a proteinaceous substance with cytotoxic and enterotoxic activity isolated from the soluble fraction of sonicated axenically cultivated Entamoeba histolytica trophozoites. Demonstration of cytotoxic activity of the preparation (amebal toxin) was dependent on removal of serum from the tissue culture assay system. The objective of the present study was to identify the factor(s) in non-immune sera responsible for producing in vitro inhibition of amebal toxin cytotoxicity on HeLa cells. Gel filtration of non-immune sera from adult humans or bovines demonstrated that two portions of the eluate had significant inhibitory against the toxin. A high molecular weight inhibitory fraction was identified as predominantly alpha-2 macroglobulin and a low molecular weight inhibitory fraction was identified as predominantly alpha-1 antiprotease. Preparative isoelectric focusing of human serum isolated inhibitory fractions containing these same alpha globulins. Alpha-2 macroglobulin was purified and alpha-1 antiprotease was partially purified from human serum by other methods and shown to have high inhibitory activity against the amebal cytotoxin. Substances that were inhibitory to the cytotoxic activity of the amebal toxin also mediated reattachment of toxin treated HeLa cells. We conclude that the characteristics of the serum inhibitors, especially their ability to reverse the cytotoxic effects of amebal toxin on HeLa cells, suggests that the amebal toxin has protease activity.
我们之前报道过,从经超声处理的无菌培养溶组织内阿米巴滋养体的可溶性部分中分离出一种具有细胞毒性和肠毒性活性的蛋白质物质,并进行了部分纯化。制剂(阿米巴毒素)细胞毒性活性的证明取决于从组织培养测定系统中去除血清。本研究的目的是确定非免疫血清中负责在体外抑制阿米巴毒素对HeLa细胞细胞毒性的因素。对成人或牛的非免疫血清进行凝胶过滤表明,洗脱液的两个部分对毒素具有显著抑制作用。高分子量抑制部分主要鉴定为α-2巨球蛋白,低分子量抑制部分主要鉴定为α-1抗蛋白酶。人血清的制备性等电聚焦分离出含有这些相同α球蛋白的抑制部分。通过其他方法从人血清中纯化了α-2巨球蛋白并部分纯化了α-1抗蛋白酶,结果显示它们对阿米巴细胞毒素具有高抑制活性。抑制阿米巴毒素细胞毒性活性的物质也介导了毒素处理的HeLa细胞的重新附着。我们得出结论,血清抑制剂的特性,尤其是它们逆转阿米巴毒素对HeLa细胞细胞毒性作用的能力,表明阿米巴毒素具有蛋白酶活性。